Item Type | Name |
Concept
|
Mycobacterium tuberculosis
|
Concept
|
Tuberculosis, Meningeal
|
Concept
|
Tuberculosis, Multidrug-Resistant
|
Concept
|
Tuberculosis, Pulmonary
|
Concept
|
Latent Tuberculosis
|
Concept
|
Tuberculosis
|
Concept
|
Tuberculosis Vaccines
|
Academic Article
|
Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4+ T Cell Activation and Mycobacterium tuberculosis Control.
|
Academic Article
|
CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.
|
Academic Article
|
Chemokines in tuberculosis: the good, the bad and the ugly.
|
Academic Article
|
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
|
Academic Article
|
LAG3 expression in active Mycobacterium tuberculosis infections.
|
Academic Article
|
S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.
|
Academic Article
|
Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population.
|
Academic Article
|
Publisher Correction: Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
|
Academic Article
|
A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.
|
Academic Article
|
Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis.
|
Academic Article
|
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy.
|
Academic Article
|
Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.
|
Academic Article
|
Nonpathologic Infection of Macaques by an Attenuated Mycobacterial Vaccine Is Not Reactivated in the Setting of HIV Co-Infection.
|
Academic Article
|
Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection.
|
Academic Article
|
Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection.
|
Academic Article
|
HIV-1 and SIV Infection Are Associated with Early Loss of Lung Interstitial CD4+ T Cells and Dissemination of Pulmonary Tuberculosis.
|
Academic Article
|
CXCL17 Is Dispensable during Hypervirulent Mycobacterium tuberculosis HN878 Infection in Mice.
|
Academic Article
|
In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis.
|
Academic Article
|
In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity.
|
Academic Article
|
Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.
|
Academic Article
|
Vaccines against tuberculosis: moving forward with new concepts.
|
Academic Article
|
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model.
|
Academic Article
|
Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551.
|
Academic Article
|
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model.
|
Academic Article
|
Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
|
Academic Article
|
IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination.
|
Academic Article
|
Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis.
|
Academic Article
|
IL-23 and IL-17 in tuberculosis.
|
Academic Article
|
Formation of Lung Inducible Bronchus Associated Lymphoid Tissue Is Regulated by Mycobacterium tuberculosis Expressed Determinants.
|
Academic Article
|
Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
|
Academic Article
|
IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.
|
Academic Article
|
Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model.
|
Academic Article
|
A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis.
|
Academic Article
|
The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.
|
Academic Article
|
Cytokines and Chemokines in Mycobacterium tuberculosis Infection.
|
Academic Article
|
Lipocalin 2 regulates inflammation during pulmonary mycobacterial infections.
|
Academic Article
|
Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.
|
Academic Article
|
Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis.
|
Academic Article
|
The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.
|
Academic Article
|
Targeting innate immunity for tuberculosis vaccination.
|
Academic Article
|
Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice.
|
Academic Article
|
Interleukin-17 limits hypoxia-inducible factor 1a and development of hypoxic granulomas during tuberculosis.
|
Academic Article
|
Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
|
Academic Article
|
The immunoregulatory landscape of human tuberculosis granulomas.
|
Academic Article
|
Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.
|
Academic Article
|
Interleukin-12 and tuberculosis: an old story revisited.
|
Academic Article
|
A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.
|
Academic Article
|
Author Correction: The immunoregulatory landscape of human tuberculosis granulomas.
|
Academic Article
|
Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis.
|
Academic Article
|
IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice.
|
Academic Article
|
Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes.
|
Academic Article
|
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.
|
Academic Article
|
Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1.
|
Academic Article
|
Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB.
|
Academic Article
|
CXCR5? T helper cells mediate protective immunity against tuberculosis.
|
Academic Article
|
Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis.
|
Academic Article
|
Immune correlates of tuberculosis disease and risk translate across species.
|
Academic Article
|
Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
|
Academic Article
|
The DosR Regulon Modulates Adaptive Immunity and Is Essential for Mycobacterium tuberculosis Persistence.
|
Academic Article
|
IL-17 in protective immunity to intracellular pathogens.
|
Academic Article
|
Profiling early lung immune responses in the mouse model of tuberculosis.
|
Academic Article
|
Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration.
|
Academic Article
|
S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis.
|
Academic Article
|
Chronic Immune Activation in TB/HIV Co-infection.
|
Academic Article
|
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.
|
Academic Article
|
IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung.
|
Academic Article
|
Rifampin resistance mutations in the rpoB gene of Enterococcus faecalis impact host macrophage cytokine production.
|
Academic Article
|
The immune landscape in tuberculosis reveals populations linked to disease and latency.
|
Academic Article
|
Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
|
Academic Article
|
Immunometabolism during Mycobacterium tuberculosis Infection.
|
Academic Article
|
Chemokines shape the immune responses to tuberculosis.
|
Academic Article
|
Mycobacterium tuberculosis HN878 Infection Induces Human-Like B-Cell Follicles in Mice.
|
Academic Article
|
CWHM-12, an Antagonist of Integrin-Mediated Transforming Growth Factor-Beta Activation Confers Protection During Early Mycobacterium tuberculosis Infection in Mice.
|
Academic Article
|
Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control.
|
Academic Article
|
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production.
|
Academic Article
|
Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons.
|
Academic Article
|
Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.
|
Academic Article
|
A protocol to analyze single-cell RNA-seq data from Mycobacterium tuberculosis-infected mice lung.
|
Academic Article
|
Mycobacterium tuberculosis infection drives differential responses in the bone marrow hematopoietic stem and progenitor cells.
|
Grant
|
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
|
Grant
|
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
|
Grant
|
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
|
Grant
|
Novel IL-17 producing memory cells are key to vaccine-based immunity in the lung
|
Grant
|
ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSIS
|
Grant
|
Novel IL-17 producing memory cells are key to vaccine-based immunity in the lung
|
Grant
|
MODIFYING THE LUNG TO INDUCE STERILE VACCINE-INDUCED PROTECTION AGAINST MTB INFECTION
|
Grant
|
The Role of Group 3 Innate Lymphoid cells (ILC3) in Tuberculosis
|
Grant
|
Impact of mucosal immunization on generation of protective lung-resident IL-17 pr
|
Grant
|
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
|
Academic Article
|
Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in mice.
|
Academic Article
|
NF-?B signaling deficiency in CD11c-expressing phagocytes mediates early inflammatory responses and enhances Mycobacterium tuberculosis control.
|
Academic Article
|
Lung type 3 innate lymphoid cells respond early following Mycobacterium tuberculosis infection.
|
Academic Article
|
Phospholipase C epsilon-1 (PLC?1) mediates macrophage activation and protection against tuberculosis.
|
Academic Article
|
A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y.
|